A recent report suggested that the catalytic subunit CnAβ is required for sustained Ang-II-induced hypertension but not for its induction, since constitutive CnAβ deletion did not prevent Ang-II-induced hypertension during the first 3 weeks of treatment but did cause a decrease in systolic BP 1 week later [33]. The gene discussed is AGT; the disease is Hypertension.